ESPERION THERAPEUTICS INC. - COMMON STOCK

Esperion to Participate in H.C. Wainwright 25th Annual Global Investment Conference

28 أغسطس 2023 07:00:00 بحسب Nasdaq GlobeNewswire

Esperion Presents Two CLEAR Outcomes Study Late-Breakers at European Society of Cardiology Congress 2023

26 أغسطس 2023 10:00:00 بحسب Nasdaq GlobeNewswire

Two CLEAR Outcomes Study Late-Breakers Accepted at European Society of Cardiology (ESC) Congress 2023

11 أغسطس 2023 07:00:00 بحسب Nasdaq GlobeNewswire

Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

08 أغسطس 2023 15:15:00 بحسب Nasdaq GlobeNewswire

Esperion Reports Second Quarter 2023 Financial Results

01 أغسطس 2023 05:00:00 بحسب Nasdaq GlobeNewswire

Esperion to Report Second Quarter 2023 Financial Results on August 1

17 يوليو 2023 05:00:00 بحسب Nasdaq GlobeNewswire

Esperion to Present Additional Data from the CLEAR Outcomes Study on CVD Prevention at the American Society for Preventive Cardiology (ASPC) Congress 2023

07 يوليو 2023 07:00:00 بحسب Nasdaq GlobeNewswire

Esperion Announces Submission of Application for Expanded Indication with the European Medicines Agency (EMA) for NILEMDO® (bempedoic acid) Tablet and NUSTENDI® (bempedoic acid and ezetimibe) Tablet

28 يونيو 2023 07:00:01 بحسب Nasdaq GlobeNewswire

Esperion Presents Results from CLEAR Outcomes Primary Prevention Analysis at 83rd American Diabetes Association Scientific Sessions

24 يونيو 2023 13:30:00 بحسب Nasdaq GlobeNewswire

Esperion Presents Results from New Analysis on Cardiovascular Benefits with Bempedoic Acid Treatment at ENDO 2023

15 يونيو 2023 13:30:00 بحسب Nasdaq GlobeNewswire

Esperion to Present New Key Science at the American Diabetes Association’s 83rd Scientific Sessions 2023

08 يونيو 2023 07:00:00 بحسب Nasdaq GlobeNewswire

Esperion to Present Additional Analyses from the Landmark CLEAR Outcomes Study at ENDO 2023

05 يونيو 2023 07:00:01 بحسب Nasdaq GlobeNewswire

Esperion Announces Submission of Supplemental New Drug Applications to U.S. FDA for NEXLETOL® (bempedoic acid) Tablet and NEXLIZET® (bempedoic acid and ezetimibe) Tablet

01 يونيو 2023 07:00:01 بحسب Nasdaq GlobeNewswire

Esperion Announces Adjournment of 2023 Annual Meeting of Stockholders

25 مايو 2023 15:30:00 بحسب Nasdaq GlobeNewswire

Esperion to Participate in Jefferies Healthcare Conference

24 مايو 2023 07:00:01 بحسب Nasdaq GlobeNewswire

Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

12 مايو 2023 15:30:00 بحسب Nasdaq GlobeNewswire

Esperion Reports First Quarter 2023 Financial Results

09 مايو 2023 06:00:02 بحسب Nasdaq GlobeNewswire

Esperion Retains Gibson Dunn to Secure $300 Million Payment From DSE; Will Announce First Quarter Financial Results Tuesday, May 9

04 مايو 2023 07:30:00 بحسب Nasdaq GlobeNewswire

Esperion to Participate in JMP Securities Life Sciences Conference

01 مايو 2023 07:00:01 بحسب Nasdaq GlobeNewswire

Esperion to Participate in Bank of America Securities 2023 Health Care Conference

27 أبريل 2023 07:00:01 بحسب Nasdaq GlobeNewswire